Gina Buckley, MT, MS
- 2Articles
- 7.5KReads
- 2013–2015Active
- 11Collaborators
- 113Citations
About
Gina Buckley, MT, MS, has published research on major depressive disorder and the genetic factors influencing treatment. Her work includes studies on adverse events following discontinuation of desvenlafaxine and the role of cytochrome P450 2D6 phenoconversion in depression treatment. Buckley's publications appeared between 2013 and 2015 in Psychiatrist.com journals.
Publications
Incidence and Timing of Taper/Posttherapy-Emergent Adverse Events Following Discontinuation of Desvenlafaxine 50 mg/d in Patients With Major Depressive Disorder
February 5, 2015
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
